Literature DB >> 10230753

Helicobacter pylori and gastric cancer.

J M Scheiman1, A F Cutler.   

Abstract

Infection with Helicobacter pylori is now recognized as the primary cause of peptic ulcers and their recurrence. Compelling evidence has also been found linking H. pylori infection to gastric cancer, the second most common cancer in the world. Given the high rate of patient morbidity and mortality associated with gastric cancer, any method by which one can reduce the occurrence of the disease or increase its early detection is desirable. The strong correlation with H. pylori infection and the current availability of easily administered tests for the detection of the pathogen argue for screening at least those individuals with a family history of gastric cancer or other risk factors. This article reviews the association between H. pylori and gastric cancer and the pathologic changes that the infection produces in the gastric mucosa, as well as the cost-effectiveness of universal testing and eradication of the infection in H. pylori-positive individuals to reduce gastric cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10230753     DOI: 10.1016/s0002-9343(98)00393-3

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

1.  Transmission of Helicobacter pyori in an animal model.

Authors:  L Cellini; L Marzio; G Ferrero; A Del Vino; E Di Campli; L Grossi; S Toracchio; L Artese
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Resveratrol and red wine extracts inhibit the growth of CagA+ strains of Helicobacter pylori in vitro.

Authors:  Gail B Mahady; Susan L Pendland; Lucas R Chadwick
Journal:  Am J Gastroenterol       Date:  2003-06       Impact factor: 10.864

3.  Helicobacter pylori infection is associated with a high incidence of intestinal metaplasia in the gastric mucosa of patients at inner-city hospitals in New York.

Authors:  J Schneller; R Gupta; J Mustafa; R Villanueva; E W Straus; R D Raffaniello
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

4.  Evaluation of the role of H pylori infection in pathogenesis of gastric cancer by immunoblot assay.

Authors:  Kuo-Ching Yang; Alexander Chu; Chao-Sheng Liao; Yu-Min Lin; Gen-Min Wang
Journal:  World J Gastroenterol       Date:  2006-11-21       Impact factor: 5.742

5.  Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients.

Authors:  Anna Lundgren; Erika Strömberg; Asa Sjöling; Catharina Lindholm; Karin Enarsson; Anders Edebo; Erik Johnsson; Elisabeth Suri-Payer; Pia Larsson; Anna Rudin; Ann-Mari Svennerholm; B Samuel Lundin
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 6.  Surgical management of gastric cancer: the East vs. West perspective.

Authors:  Maki Yamamoto; Omar M Rashid; Joyce Wong
Journal:  J Gastrointest Oncol       Date:  2015-02

7.  Commentary: eight ways to prevent cancer: a framework for effective prevention messages for the public.

Authors:  Hank Dart; Kathleen Y Wolin; Graham A Colditz
Journal:  Cancer Causes Control       Date:  2012-02-26       Impact factor: 2.506

8.  Standardized ginger (Zingiber officinale) extract reduces bacterial load and suppresses acute and chronic inflammation in Mongolian gerbils infected with cagAHelicobacter pylori.

Authors:  Kristen Gaus; Yue Huang; Dawn A Israel; Susan L Pendland; Bolanle A Adeniyi; Gail B Mahady
Journal:  Pharm Biol       Date:  2009       Impact factor: 3.503

Review 9.  Laboratory tests for the evaluation of Helicobacter pylori infections.

Authors:  R M Nakamura
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

10.  Ginger (Zingiber officinale Roscoe) and the gingerols inhibit the growth of Cag A+ strains of Helicobacter pylori.

Authors:  Gail B Mahady; Susan L Pendland; Gina S Yun; Zhi-Zhen Lu; Adina Stoia
Journal:  Anticancer Res       Date:  2003 Sep-Oct       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.